Gene: ARPC5L
Official Full Name: actin related protein 2/3 complex subunit 5 likeprovided by HGNC
Gene Summary: Predicted to enable actin filament binding activity. Predicted to be involved in Arp2/3 complex-mediated actin nucleation and cell migration. Located in extracellular exosome and focal adhesion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02075 | ARPC5L Knockout cell line (HeLa) | Human | ARPC5L | 1:3~1:6 | Negative | Online Inquiry |
KO02076 | ARPC5L Knockout cell line (HCT 116) | Human | ARPC5L | 1:2~1:4 | Negative | Online Inquiry |
KO02077 | ARPC5L Knockout cell line (HEK293) | Human | ARPC5L | 1:3~1:6 | Negative | Online Inquiry |
KO02078 | ARPC5L Knockout cell line (A549) | Human | ARPC5L | 1:3~1:4 | Negative | Online Inquiry |
ARPC5L Gene Knockout Cell Lines are genetically engineered cellular models designed to facilitate the study of the ARPC5L gene, which encodes a vital component of the actin-regulating complexes involved in cytoskeletal dynamics. These cell lines are created through cutting-edge CRISPR-Cas9 technology, resulting in stable knockout configurations that allow researchers to investigate the role of ARPC5L in various biological processes, such as cell migration, adhesion, and proliferation, by alleviating the function of this gene.
The key mechanism of these knockout cell lines lies in the specific and precise disruption of the ARPC5L gene, which effectively negates its protein expression. By doing so, researchers can observe the phenotypic and behavioral changes that occur in cellular activity, providing insights into the gene's function in normal physiological conditions and disease states, such as cancer or developmental disorders. This model is particularly useful in elucidating molecular pathways associated with actin polymerization and its impact on cellular integrity and function.
The scientific importance of ARPC5L Gene Knockout Cell Lines is underscored by their wide applicability in both basic and applied research. In clinical settings, these cell lines can aid in drug discovery and therapeutics targeting cytoskeletal components and their associated pathways, potentially leading to innovative treatments for diseases characterized by cytoskeletal dysfunction.
What sets our ARPC5L Gene Knockout Cell Lines apart from other knockout models is their superior stability and reproducibility, ensuring consistent results across experiments. Furthermore, they come with comprehensive documentation and targeted technical support that enhances ease of use. Researchers and clinicians will find our product indispensable for advanced studies into the implications of ARPC5L in health and disease.
As a leader in genetic engineering solutions, our company is dedicated to developing high-quality biological products tailored to meet the rigorous demands of modern research and clinical applications, ensuring that scientists have the tools they need to drive innovation and discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.